Navigation Links
Fugitive Who Ditched His Ailing Son Arrested After a Year
Post Your Comments:
(Date:11/20/2008)...10 Precision Therapeutics Inc., a ...onse tests, has secured $43 million,in additional...zation of,ChemoFx(R). ChemoFx is a diagnostic te...e chemotherapeutic regimen for cancer patients. N...d the round and was joined by existing,investors ...
(Date:11/20/2008)...Nov. 20 Yesterday, Amer...he health insurance industry had decided to suppor... to buy health insurance or pay a fine, combined w... be accepted regardless of health status. , ,...e (CAHI), which has several health insurance compa...
(Date:11/20/2008)... Nov. 20 An investor group in Trin... developer and manufacturer of,diagnostic product...Depository,Receipts on NASDAQ, is encouraged that... directors. , Commenting on the news, Tom R...eed to serve as an independent director, bringing ...
(Date:11/20/2008)... tending Alzheimer,s relatives at risk for hospita... 20 (HealthDay News) -- The stress of providing ca...percent of family caregivers having at least one e...says an Indiana University study. , It,s long ... patient is difficult, but the Indiana University ...
Breaking Medicine News(10 mins):Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 3Health News:CAHI Stands by Its Principles for Health Insurance Reform 2Health News:Investor Group Commends Clint Severson for Joining Trinity Biotech's Board of Directors 2Health News:When the Caregiver Becomes the Patient 2
...University of Wisconsin-Madison Center of Excellen...ed by the National Cancer Institute// finds that B...roups can obtain mental health benefits. ‘We kno...line support groups to help them cope with their i...
...viate symptoms of early-stage Parkinson's disease,...lls to manage the brain disorder,// researchers sa...German pharmaceutical was used to study its effect...ed States suffering early-stage Parkinson's. The p...
... in Singapore is using a customised personal digit...es of the intellectually disabled,// innovators sa...ctures, the handheld innovation helps those with s...in such everyday tasks as ordering food or asking ...
.... However it is regarded as a psychological disord...cently //presented a doctoral thesis on this topic...rd of all women patients who suffered from bulimia...ic disorders. The study points of that this disord...
Other Medicine News:Health News:Online Prayers Helps Cancer Patients 2Health News:Excessive Male Hormones can Cause Bulimia in Women 2
(Date:11/19/2008)...tical significance , , ISELIN, N.J., Nov. 1...Nasdaq: PARS ) today announced results from its ...n (NE) drug delivery technology formulated with 3%...enter, randomized, double-blinded, placebo-control... Company,s 3% Diclofenac Diethanolamine NanoEmulsi...
(Date:11/19/2008)... -- Biotech scientists increasingly are applying g...ter understand the effects of novel drug candidate...Engineering & Biotechnology News ( GEN ). The...compound,s mechanism of action and eventually deve...g to the November 15 issue of GEN . ( http://www....
(Date:11/19/2008)... , , MONTVALE, N.J., Nov. 19 /PRNewswire-Fi... MEMY ) today announced that it has achieved the ... 3454, its lead alpha-7 nicotinic receptor agonist...renia (CIAS). The Company has randomized 212 pati...on payment from its partner Roche. Memory Pharmac...
(Date:11/18/2008)...more, make a donation or send a Christmas Seals e-...Newswire/ -- Millions will receive Christmas Seals...Lung Association. These decorative holiday stamps ... back to 1907 when the Lung Association led effort...icans alive today have no vivid memories of how wi...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Tick borne encephalitis virus reveals its access code 5456 1A dinosaur dance floor 5453 1A dinosaur dance floor 5453 2A dinosaur dance floor 5453 3A dinosaur dance floor 5453 4A dinosaur dance floor 5453 5Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC IDSA 3308 1Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC IDSA 3308 2Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC IDSA 3308 3Bird flu vaccine protects people and pets 5451 1Bird flu vaccine protects people and pets 5451 2
... Minimal Weight Change Reported Unlike What Is Com...2007 – Novo Nordisk today announced,results ...y and,efficacy of insulin Levemir® (insulin de...e 2 diabetes were able to adjust,their own dosage ...sugar, comparable to dosing adjusted by their prim...
...CHICAGO--(BUSINESS WIRE)--Jun 25, 2007 - New data ...ican Diabetes Association,(ADA) 67th Annual Scient...apy with Januvia(TM) (sitagliptin) and metformin,d...beta cell,function in patients with type 2 diabete...the ability of the body to produce,insulin, a horm...
Other Medicine Technology:New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 2New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 3New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 4New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 5An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 2An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 3An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 4An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 5An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 6An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 7An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 8An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 9An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 10An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 11An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 12An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 13An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 14An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 15An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 16An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 17An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 18An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 19An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 20An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 21An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 22An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 23An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 24An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 25An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 26An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 27An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 28An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 29An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 30An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 31An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 32
1000 L, Racked, 96 tips/rack, clear Recommended for 500 and 1000 L pipettes.
300 L, Racked, 96 tips/rack Recommended for 250 and 300 L pipettes.
RNase-free Tips
MBP's 200 ul large orifice tip is perfect for handling fragile cells, viscous samples and genomic.
Medicine Products: